{"id":"W2751912349","doi":"10.1016/j.ygyno.2017.08.022","title":"Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2","year":2017,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Centre Hospitalier de l’Université de Montréal; University Health Network; Princess Margaret Cancer Centre","funders":"National Institute for Health and Care Research; Cancer Research UK; Clovis Oncology","keywords":"Medicine; Germline; Germline mutation; Somatic cell; PARP inhibitor; Poly ADP ribose polymerase; Ovarian carcinoma; Cancer research; Ovarian cancer; Mutation; Oncology; Polymerase; Internal medicine; Cancer; Genetics; Biology; DNA; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005317951,0.0002117643,0.001129332,0.0001981695,0.0001768533,0.00002391851,0.0002682685,0.0001769788,0.0003778438],"category_scores_gemma":[0.000853436,0.00011652,0.00002999285,0.0003942118,0.0007217288,0.0002177595,0.0003224713,0.0002434198,4.14746e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001479596,"about_ca_system_score_gemma":0.0004511958,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002100852,"about_ca_topic_score_gemma":0.0224104,"domain_scores_codex":[0.9980811,0.0003967883,0.0005587729,0.0005493502,0.0002166386,0.0001973173],"domain_scores_gemma":[0.9969353,0.0010083,0.000826039,0.0009940899,0.0001504677,0.00008578367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006735713,0.001775253,0.9839277,0.00005683737,0.0008730626,0.00008523891,0.0008390877,0.000005991156,0.0005368621,0.00001133073,0.00005504689,0.005097878],"study_design_scores_gemma":[0.01710138,0.004118819,0.9751722,0.00006660404,0.001349695,0.00001010044,0.0006479823,0.0009337579,0.0003370376,0.0000634766,0.00007251994,0.000126405],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996916,0.00005130532,0.0000389549,0.0009989219,0.0001122898,0.001327763,0.0004984688,0.0000120183,0.00004428985],"genre_scores_gemma":[0.998433,0.00003579031,0.001132811,0.0001100396,0.00002846178,0.00004826883,0.0001405725,0.00001148186,0.00005955868],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02030955,"threshold_uncertainty_score":0.9954281,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05371604839042909,"score_gpt":0.3439074718825645,"score_spread":0.2901914234921354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}